Late recurrence of small-cell lung cancer: A case report

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 23, Issue 5, 2000, Pages 473-475

  Kanemoto, Kouji ^a   Satoh, Hiroaki ^a   Yamashita, Yuko T ^a   Ishikawa, Hiroichi ^a   Kamma, Hiroshi ^a   Ohtsuka, Morio ^a   Sekizawa, Kiyohisa ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Late recurrence; Small cell lung cancer; Treatment

Indexed keywords

CISPLATIN;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; LUNG SMALL CELL CANCER; MALE; OSTEOLYSIS;

AGED; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; OSTEOLYSIS; RIBS; SOFT TISSUE NEOPLASMS;

EID: 0034443950     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200010000-00008     Document Type: Article

References (15)

1. Chemotherapy of lung cancer
2. Long-term survival and toxicity in small cell lung cancer: Expanded Southwest Oncology Group experience
3. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years
4. A preliminary report: Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer
5. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer
6. Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: A Southwest Oncology Group study
7. Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: A pilot study of the Eastern Cooperative Oncology Group
8. Cisplatin and etoposide plus concurrent thoracic radiotherapy administered once versus twice daily for limited-stage small cell lung cancer: Preliminary results of an intergroup trial
9. The incidence of second primary tumors in long-term survivors of small-cell lung cancer
10. Long-term survival in small-cell lung cancer: Post-treatment characteristics in patients surviving 5 to 18+ years: An analysis of 1,714 consecutive patients
11. Longevity in small cell lung cancer: A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research
12. Analysis of long-term survivors with small-cell lung cancer
13. Retreatment of patients surviving cancer-free 2 or more years after initial treatment of small cell lung cancer
14. Late recurrence of small-cell lung cancer: Treatment and outcome
15. Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer